Medical News

RSS

International research team identifies new gene associated with 4H leukodystrophy

Leukodystrophies are deadly neurodegenerative diseases that affect one in 7,000 children and remain incurable. These genetic diseases attack myelin or the "insulating rubber sheath" surrounding neurons, which leads to deteriorating health for affected children.

9 Jul 2015

UK study suggests new approach to develop highly-potent drugs

A new study led by University of Kentucky researchers suggests a new approach to develop highly-potent drugs which could overcome current shortcomings of low drug efficacy and multi-drug resistance in the treatment of cancer as well as viral and bacterial infections.

9 Jul 2015

U-M researchers develop first-ever 3D model to help study treatment for pelvic organ prolapse

It's a mysterious condition often linked to childbirth that causes distress and discomfort and requires surgery for more than 200,000 women a year - but there's no good way to study it. Now, researchers at the University of Michigan have developed the first-ever 3D complete computer model to help study treatment for pelvic organ prolapse, a weakening of muscles and ligaments that causes organs like the bladder to drop from their normal place. For many women, the condition causes urinary problems, painful intercourse and uncomfortable pressure.

9 Jul 2015

Internet-based program can help people manage their chronic pain, reduce reliance on opioids

Washington State University researchers have found that people can manage chronic pain and reduce their reliance on opioids through an Internet-based program that teaches non-medical alternatives like increased physical activity, thinking more positively and dealing with emotions.

8 Jul 2015

New research identifies potential treatment for primary effusion lymphoma

New research from the University of Southern California Norris Comprehensive Cancer Center has identified a potential treatment for a rare but previously incurable form of lymphoma that is observed primarily in patients with HIV/AIDS infection.

8 Jul 2015

Ludwig, CRI launch clinical trials to evaluate immunotherapies for treatment of GBM and solid tumors

Ludwig Cancer Research and the Cancer Research Institute have launched clinical trials evaluating an immunotherapy for the treatment of the brain cancer glioblastoma multiforme (GBM), and a combination of immunotherapies for a variety of solid tumors.

8 Jul 2015

LUX-Lung 8 supports afatinib in squamous NSCLC

Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.

8 Jul 2015

Surgery delays for elderly patients with traumatic spinal cord injury

Older patients with traumatic spinal cord injury experience significant delays in being transferred to a specialist treatment centre and receiving surgery, compared with younger patients, study findings show.

8 Jul 2015

DME treatment evolves in favour of intravitreal anti-VEGF injections

Treatment strategies for diabetic macular oedema have evolved over the past decade, with focal laser therapy being largely replaced by intravitreal injections, an observational case series of more than 1500 patients shows.

8 Jul 2015

Retinal function, structure changes in proliferative diabetic retinopathy revealed

Patients with proliferative diabetic retinopathy exhibit marked visual dysfunction and structural changes in both the inner and outer retinal layers, research findings indicate.

8 Jul 2015

Macular atrophy predicts vision in ranibizumab-treated exudative AMD patients

Progression and severity of macular atrophy are the main anatomical determinants of long-term visual outcomes in exudative age-related macular degeneration patients treated with ranibizumab, suggest SEVEN-UP study results.

8 Jul 2015

Darapladib shows promise in diabetic macular oedema

Placebo-controlled trial findings show that lipoprotein-associated phospholipase A2 inhibition modestly benefits the vision of patients with centre-involved diabetic macular oedema and warrants further investigation.

8 Jul 2015

Scientists elucidate which mechanisms block natural killer cells and how this could be lifted

Natural killer cells of the immune system can fend off malignant lymphoma cells and thus are considered a promising therapeutic approach. However, in the direct vicinity of the tumor they lose their effect.

8 Jul 2015

Novartis announces FDA approval of Entresto to reduce risk of cardiovascular death, heart failure hospitalization

Novartis announced today that the US Food and Drug Administration has approved Entresto™ tablets, previously known as LCZ696, to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure and reduced ejection fraction.

8 Jul 2015

ImmunID announces publication of clinical study data on ImmunTraCkeR assay in the Journal for ImmunoTherapy of Cancer

ImmunID today announced the publication of a short report in the Journal for ImmunoTherapy of Cancer showing that the analysis of peripheral T cell receptor diversity using the company's ImmunTraCkeR assay is associated with clinical outcomes following Ipilimumab treatment in metastatic melanoma.

8 Jul 2015

First-of-its-kind 'Transitional Care' provider starts treating Medicare patients

A first-of-its-kind provider group has begun treating Medicare patients who have been discharged from hospitals and post-acute care facilities under a newly launched Centers for Medicare & Medicaid Services (CMS) designation called ‘Transitional Care.’

8 Jul 2015

Amedica receives FDA feedback on proposed wear testing femoral head protocols

Amedica Corporation, a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced that responses to the U.S. Food and Drug Administration inquiries regarding the Company’s cervical composite silicon nitride interbody device were submitted to the FDA on June 30, 2015.

8 Jul 2015

Avita Medical donates ReCell devices, sends experienced personnel to help treat burn victims in Taiwan

Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, has donated a number of free ReCell devices and sent personnel experienced in burn treatment to provide any support requested by authorities in Taiwan, where hundreds of people have been left seriously burned in a mass casualty event at a waterpark.

8 Jul 2015

Galmed signs License Agreement for development of blood-based companion diagnostic tool

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases, announced today that it has entered into a Research, Option and License Agreement ("License Agreement") and a Share Purchase Agreement with One Way Liver Genomics S.L., for the development of a non-invasive, blood-based companion diagnostic tool.

8 Jul 2015

Free, online resource introduced for patients and healthcare professionals in Canada

MarijuanaMedInfo Inc. today introduced www.MarijuanaMedInfo.ca a free, online resource for patients and healthcare professionals. The website provides scientific, clinical, regulatory, reimbursement and access information on the medical use of marijuana.

8 Jul 2015

Medical News

International research team identifies new gene associated with 4H leukodystrophy

UK study suggests new approach to develop highly-potent drugs

U-M researchers develop first-ever 3D model to help study treatment for pelvic organ prolapse

Internet-based program can help people manage their chronic pain, reduce reliance on opioids

New research identifies potential treatment for primary effusion lymphoma

Ludwig, CRI launch clinical trials to evaluate immunotherapies for treatment of GBM and solid tumors

LUX-Lung 8 supports afatinib in squamous NSCLC

Surgery delays for elderly patients with traumatic spinal cord injury

DME treatment evolves in favour of intravitreal anti-VEGF injections

Retinal function, structure changes in proliferative diabetic retinopathy revealed

Macular atrophy predicts vision in ranibizumab-treated exudative AMD patients

Darapladib shows promise in diabetic macular oedema

Scientists elucidate which mechanisms block natural killer cells and how this could be lifted

Novartis announces FDA approval of Entresto to reduce risk of cardiovascular death, heart failure hospitalization

ImmunID announces publication of clinical study data on ImmunTraCkeR assay in the Journal for ImmunoTherapy of Cancer

First-of-its-kind 'Transitional Care' provider starts treating Medicare patients

Amedica receives FDA feedback on proposed wear testing femoral head protocols

Avita Medical donates ReCell devices, sends experienced personnel to help treat burn victims in Taiwan

Galmed signs License Agreement for development of blood-based companion diagnostic tool

Free, online resource introduced for patients and healthcare professionals in Canada

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News